IL4 and allergic disease: It has also been reported that QCT inhibits the antigen-immunoglobulin E mediated tumor necrosis factors-α and IL-4 production in Type I allergic reactions and concomitantly decreases the expression of Th2-type cytokines (IL-4, IL-13, and IL-5) by basophils (11).